Personalized testing Leverage Compass Laboratory Services’ focus on personalized medicine and genetic risk profiling to position high-value molecular diagnostics and cardiometabolic testing as essential tools for precision treatment plans in provider networks and accountable care organizations.

SmallScale to mid Target mid-sized health systems and specialty clinics seeking advanced diagnostics but with lean operations, highlighting Compass as a nimble partner capable of integrating prescription drug management testing and new HPV oral detection offerings without the scale burdens of larger reference labs.

Expansion history Opportunity to cross-sell or partner around the OraGen HPV launch and the Genome Explorations acquisition legacy, framing Compass as an innovative provider expanding capabilities in genomics and oral cancer risk diagnostics to improve screening pathways.

Technology fit Position Compass as a cloud-enabled diagnostics partner with modern data infrastructure (Google Cloud, Microsoft Azure) to offer secure data integration, seamless report delivery, and interoperability with EHRs for patients’ personalized care journeys.

Growth posture With revenue under one million and a growth-oriented portfolio, pursue collaboration opportunities in contract research, clinical trial support, or payer-backed diagnostic programs where Compass can scale testing services, lab capabilities, and fast turnaround times for high-complexity tests.